Survival of Allogeneic Hematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: Have We Reached the Limits?

Allogeneic Haematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: Survival and Prognosis

“…Of course, the study population in our study is quite small and not sufficient to change entire guidelines, but it gives a strong indication in the direction of recommending short ICU admissions. Aydoğdu and Esquinas [4] compare our findings with those of van Vliet et al [5], but this study is different from ours in a number of ways, e.g. only including ICU admissions up to 100 days after HSCT, and with only 57% of the patients having engraftment compared to our 79.6%.…”